about
Two-stage vs mixed-effect approach to pharmacodynamic modeling of propofol in children using state entropy.Propofol and children--what we know and what we do not know.Total intravenous anesthesia (TIVA) in pediatric cardiac anesthesia.Total intravenous anesthesia will supercede inhalational anesthesia in pediatric anesthetic practice.Optimization of initial propofol bolus dose for EEG Narcotrend Index-guided transition from sevoflurane induction to intravenous anesthesia in children.Cerebral responses to local and global auditory novelty under general anesthesiaRobust closed-loop control of induction and maintenance of propofol anesthesia in children.Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.Evaluation of the aepEX™ monitor of hypnotic depth in pediatric patients receiving propofol-remifentanil anesthesia.A delayed functional observer/predictor with bounded-error for depth of hypnosis monitoring.Propofol concentration to induce general anesthesia in children aged 3-11 years with the Kataria effect-site model.Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.Pharmacodynamic modeling of propofol-induced tidal volume depression in children.Importance of model fitting when a non-commercial TCI system was used: taking Kataria's parameter as an example.Effect site concentrations of propofol producing hypnosis in children and adults: comparison using the bispectral index.
P2860
Q34180328-B7E31FF8-0400-44E5-A120-EF993E4B1BC5Q37810340-1086CF4A-2FF0-4352-9F24-91D23F473FFAQ37852789-C68946E9-BADE-42F5-95A1-3311B0E09F60Q38259932-F3004AE0-CA0B-4C2D-9BD7-F7FA7F2FE8E4Q38954301-4833C911-7908-40A0-B5CB-6AD777D38188Q42172478-EA4AFD6C-923A-4DD3-A0D3-738F16D851FFQ42598963-8FC02F51-0AE2-47D0-9696-AF2F2E431165Q42635454-06A59DC5-4DB1-4A15-914F-6EC2594D57ADQ45779159-943D34D1-3BEF-47B3-9FD2-351F426B1C0FQ47392227-2017419B-323E-4AA3-A638-CD3D35D46F62Q47720358-2EEF0988-BC31-41E3-88D2-8266E96B9565Q47742227-87EC679F-624E-4449-A64F-1136D1A628E3Q48228137-F66A6C97-F7FF-4AD9-8C4B-D04BA40D4CCFQ48288230-369167AA-CE20-4A0D-8F51-0B8C445DB492Q48676488-4BB3EB7C-4AE5-489B-A177-7A6ACA08E22F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
'Paedfusor' pharmacokinetic data set.
@en
'Paedfusor' pharmacokinetic data set.
@nl
type
label
'Paedfusor' pharmacokinetic data set.
@en
'Paedfusor' pharmacokinetic data set.
@nl
prefLabel
'Paedfusor' pharmacokinetic data set.
@en
'Paedfusor' pharmacokinetic data set.
@nl
P356
P1476
'Paedfusor' pharmacokinetic data set.
@en
P2093
P356
10.1093/BJA/AEI567
P407
P577
2005-07-01T00:00:00Z